David Church awarded a Cancer Research UK Senior Cancer Research Fellowship
25 March 2025
David Church received a Senior Cancer Research Fellowship from the Cancer Research UK Research Careers Committee to study MHC-I and MHC-II dysregulation in colorectal & endometrial cancer.
Study finds previously unidentified genetic determinants of rare disease
28 February 2025
A landmark study involving researchers from the Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.
At-home test could play key role in type-1 diabetes screening
17 February 2025
A new home test to diagnose type-1 diabetes (T1D) is being investigated in a major UK study led by researchers at the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre and NDM's Centre for Human Genetics.
Five Advance HE fellowships awarded to NDM teaching staff
12 February 2025
Five members of the MSc Genomic Medicine teaching team have been awarded Advanced HE fellowships in recognition of their roles in teaching and supporting higher education learning.
Bowel cancer prediction test for IBD patients 90% accurate
3 February 2025
Researchers in the CHG have authored a collaborative study which explored a new method for detecting bowel cancer, which was found to be more than 90% accurate at predicting which higher-risk people will develop this type of cancer in the future.
Oxford and GSK launch £50m programme to advance cancer research
27 January 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Toxic Cargoes Contributing to Dementia are Contained Within Extracellular Vesicles
17 January 2025
New research led by Dr Steph Fowler (UCL and now Oxford IMCM), Professor Karen Duff (UKDRI, UCL), with Dr Benjamin Ryskeldi-Falcon and Dr Tiana Behr (MRC LMB), have shed light on a potential pathway for the spread of harmful tau protein in Alzheimer's disease. Their findings, published in Nature Neuroscience, focus on structures called extracellular vesicles and their role in transporting toxic tau fragments.
New blood test could enable early detection of multiple cancers
8 January 2025
A new blood test – powered by machine learning – has shown real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect. Developed by a team of researchers and co-lead by the Centre for Human Genetics’ Dr Dimitris Vavoulis, the test accurately detected six cancer types and could distinguish between people with and without cancer.
Professor Anneke Lucassen is the new Academic Champion for Public and Community Engagement with Research
9 December 2024
Anneke will chair the Public and Community Engagement with Research Advisory Board and launch our 2024-2029 strategy.
Dr Nicky Whiffin awarded Balfour Lecture 2025
25 November 2024
Nicky Whiffin, Associate Professor and Sir Henry Dale Fellow at the University of Oxford’s Big Data Institute and Centre for Human Genetics, has been awarded the 2025 Balfour Lecture by the Genetics Society.